Kaiso regulates Znf131-mediated transcriptional activation

Experimental Cell Research

Volumn 316, Issue 10, 2010, Pages 1692-1705

  Donaldson, Nickett S ^a   Nordgaard, Curtis L ^a   Pierre, Christina C ^a   Kelly, Kevin F ^a   Robinson, Shaiya C ^a   Swystun, Laura ^a   Henriquez, Roberto ^a   Graham, Monica ^a   Daniel, Juliet M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

BTB POZ ZF; Kaiso; P120ctn; Transcription factor; Transcriptional activation; Znf131

Indexed keywords

BINDING PROTEIN; BROAD COMPLEX TRAMTRACK AND BRIC A BRAC POXVIRUS AND ZINC FINGER PROTEIN; PALINDROMIC DNA; PROTEIN P120 CTN; PROTEIN ZNF131; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KAISO; UNCLASSIFIED DRUG; ZNF131 BINDING ELEMENT;

ANIMAL CELL; ARTICLE; BASE PAIRING; BINDING COMPETITION; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; EPITHELIUM CELL; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE NUMBER; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TWO HYBRID SYSTEM;

EID: 77953228178     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.03.011     Document Type: Article

References (42)

1. Kelly K.F., Daniel J.M. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 2006, 16:578-587.
2. Barna M., Hawe N., Niswander L., Pandolfi P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 2000, 25:166-172.
3. Onizuka T., Moriyama M., Yamochi T., Kuroda T., Kazama A., Kanazawa N., Sato K., Kato T., Ota H., Mori S. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995, 86:28-37.
4. Niu H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 2002, 20:155-166.
5. Carter M.G., Johns M.A., Zeng X., Zhou L., Zink M.C., Mankowski J.L., Donovan D.M., Baylin S.B. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 2000, 9:413-419.
6. Piazza F., Gurrieri C., Pandolfi P.P. The theory of APL. Oncogene 2001, 20:7216-7222.
7. Kerckaert J.P., Deweindt C., Tilly H., Quief S., Lecocq G., Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat. Genet. 1993, 5:66-70.
8. Albagli O., Dhordain P., Deweindt C., Lecocq G., Leprince D. The BTB/POZ domain: A new protein-protein interaction motif common to DNA- and Actin-binding proteins. Cell Growth Differ. 1995, 6:1193-1198.
9. Bardwell V.J., Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 1994, 8:1664-1677.
10. Yoon H.-G., Chan D.W., Reynolds A.B., Qin J., Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl-CpG binding protein Kaiso. Mol. Cell 2003, 12:723-734.
11. Melnick A., Carlile G., Ahmad K.F., Kiang C.L., Corcoran C., Bardwell V., Prive G.G., Licht J.D. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 2002, 22:1804-1818.
12. Melnick A., Ahmad K.F., Arai S., Polinger A., Ball H., Borden K.L., Carlile G.W., Prive G.G., Licht J.D. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 2000, 20:6550-6567.
13. David G., Alland L., Hong S.-H., Wong C.-W., DePinho R.A., Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 1998, 16:2549-2556.
14. Dhordain P., Albagli O., Lin R.J., Ansieau S., Quief S., Leutz A., Kerckeart J.-P., Evans R.M., Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl Acad. Sci. USA 1997, 94:10762-10767.
15. Wong C.W., Privalsky M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 1998, 273:27695-27702.
16. Lemercier C., Brocard M.P., Puvion-Dutilleul F., Kao H.Y., Albagli O., Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 2002, 277:22045-22052.
17. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H., Evans R.M. Role of the histone deactylase complex in acute promyelocytic leukemia. Nature 1998, 391:811-814.
18. Deltour S., Guerardel C., Leprince D. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and FBP-B. Proc. Natl Acad. Sci. USA 1999, 96:14832-14836.
19. Deltour S., Pinte S., Guerardel C., Wasylyk B., Leprince D. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 2002, 22:4890-4901.
20. Kaplan J., Calame K. The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res. 1997, 25:1108-1116.
21. Rodova M., Kelly K.F., VanSaun M., Daniel J.M., Werle M.J. Regulation of the rapsyn promoter by Kaiso and delta-catenin. Mol. Cell Biol. 2004, 24:7188-7196.
22. Kobayashi A., Yamagiwa H., Hoshino H., Muto A., Sato K., Morita M., Hayashi N., Yamamoto M., Igarashi K. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol. Cell. Biol. 2000, 20:1733-1746.
23. Daniel J.M., Reynolds A.B. The catenin p120ctn interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell. Biol. 1999, 19:3614-3623.
24. Daniel J.M., Spring C.M., Crawford H.C., Reynolds A.B., Baig A. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 2002, 13:2911-2919.
25. Prokhortchouk A., Hendrich B., Jorgensen H., Ruzov A., Wilm M., Georgiev G., Bird A., Prokhortchouk E. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 2001, 15:1613-1618.
26. Kelly K.F., Spring C.M., Otchere A.A., Daniel J.M. NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J. Cell Sci. 2004, 117:2675-2686.
27. Spring C.M., Kelly K.F., O'Kelly I., Graham M., Crawford H.C., Daniel J.M. The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp. Cell Res. 2005, 305:253-265.
28. Kim S.W., Park J.I., Spring C.M., Sater A.K., Ji H., Otchere A.A., Daniel J.M., McCrea P.D. Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat. Cell Biol. 2004.
29. Park J.I., Kim S.W., Lyons J.P., Ji H., Nguyen T.T., Cho K., Barton M.C., Deroo T., Vleminckx K., Moon R.T., McCrea P.D. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev. Cell 2005, 8:843-854.
30. Tommerup N., Vissing H. Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. Genomics 1995, 27:259-264.
31. Trappe R., Buddenberg P., Uedelhoven J., Glaser B., Buck A., Engel W., Burfeind P. The murine BTB/POZ zinc finger gene Znf131: predominant expression in the developing central nervous system, in adult brain, testis, and thymus. Biochem. Biophys. Res. Commun. 2002, 296:319-327.
32. Kelly K.F., Otchere A.A., Graham M., Daniel J.M. Nuclear import of the BTB/POZ transcriptional regulator Kaiso. J. Cell Sci. 2004, 117:6143-6152.
33. Dhordain P., Albagli O., Honore N., Guidez F., Lantoine D., Schmid M., The H.D., Zelent A., Koken M.H. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene 2000, 19:6240-6250.
34. Donaldson N.S., Daniel Y., Kelly K.F., Graham M., Daniel J.M. Nuclear trafficking of the POZ-ZF protein Znf131. Biochim. Biophys. Acta 2007, 1773:546-555.
35. Kim S.W., Fang X., Ji H., Paulson A.F., Daniel J.M., Ciesiolka M., Roy F.v., McCrea P.D. Isolation and characterization of XKaiso, a transcriptional repressor that associates with the catenin Xp120(ctn) in Xenopus laevis. J. Biol. Chem. 2002, 277:8202-8208.
36. Phan R.T., Saito M., Basso K., Niu H., Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 2005, 6:1054-1060.
37. Pagans S., Ortiz-Lombardia M., Espinas M.L., Bernues J., Azorin F. The Drosophila transcription factor tramtrack (TTK) interacts with Trithorax-like (GAGA) and represses GAGA-mediated activation. Nucleic Acids Res. 2002, 30:4406-4413.
38. Pagans S., Pineyro D., Kosoy A., Bernues J., Azorin F. Repression by TTK69 of GAGA-mediated activation occurs in the absence of TTK69 binding to DNA and solely requires the contribution of the POZ/BTB domain of TTK69. J. Biol. Chem. 2004, 279:9725-9732.
39. Davies J.M., Hawe N., Kabarowski J., Huang Q.H., Zhu J., Brand N.J., Leprince D., Dhordain P., Cook M., Morriss-Kay G., Zelent A. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999, 18:365-375.
40. Carlberg C. RXR-independent action of the receptors for thyroid hormone, retinoid acid and vitamin D on inverted palindromes. Biochem. Biophys. Res. Commun. 1993, 195:1345-1353.
41. Vashee S., Xu H., Johnston S.A., Kodadek T. How do "Zn2 cys6" proteins distinguish between similar upstream activation sites? Comparison of the DNA-binding specificity of the GAL4 protein in vitro and in vivo. J. Biol. Chem. 1993, 268:24699-24706.
42. Han X., Guo J., Deng W., Zhang C., Du P., Shi T., Ma D. High-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling. BMC Genomics 2008, 9:476.